Chris_5339762 wrote: » Bound to happen given just how tricky this one is to store. Not good, but at least it is happening rarely.
is_that_so wrote: » It's barely out of its trials and unapproved by the EMA. It hasn't submitted an application to the EMA yet although a rolling review may start soon. We follow the EMA as do the vast majority of EU members.
ddarcy wrote: » With the US approving the Johnson and Johnson vaccination, we sound probably in March see it approved here as well. Also interesting that my parents in the US have been told that they are moving to only one vaccination for Pfizer/ Moderna as this is good enough (still 80%+ efficacy) and the Phase IV information is supporting it. So they’ll get it next week and won’t need a second dose. They’re based in California and my aunt in Massachusetts has been told the same so it all seems to be heading this way, along with the UK, so we could shortly be seeing this as the official guidelines worldwide. I’d say by April the official dosing guidelines will be changed, if the information coming back remains the same.
[Deleted User] wrote: » It was Slovakia. And did nothing to interrupt transmission with surged after the national test campaign
chrisbonnie wrote: » If only we had a pro active government. Sputnik is a very good vaccine by all accounts
conor_mc wrote: » I get your point, but was that a different outcome to PCR-tested countries that saw surges too? The positive outcome was that it identified and interrupted 47,000 otherwise invisible chains of transmission, at that point in time. I’m not advocating the same once-off approach per se, but there is an argument that as a complementary tactic, the widespread use of rapid antigen testing would help.
Happydays2020 wrote: » That’s really interesting. Certainly will speed things along.
Melanchthon wrote: » Anybody have any good articles about the US emergency Johnson and Johnson approval. Not saying it's the wrong move but it seems a funny one considering there seems to be good data now that Astra Zeneca is effective whereas the headline efficiency rate of J and J doesn't seem that high, and yes I am aware of the fact that it's basically really hospitalisation that matters as a metric so no need to repeat that point. Basically I understand the rapid approval but I don't understand reasoning behind this not applying to other vaccines in US.
Van.Bosch wrote: » If it is a very good vaccine with proper testing and data to back it up, why have the Russians not asked for approval in any major market?
is_that_so wrote: » They did or they thought they had but uploaded it to the wrong server! It'll come but probably not for a while.
Van.Bosch wrote: » Yeah, like how believable is that? “We have no application received for Sputnik” “ we applied a few days ago” “ looks like you uploaded incorrectly” “Okay, we’ll reapply in a few weeks”
bodhrandude wrote: » Where are we at in the vaccination queue here as I haven't a notion.
ninebeanrows wrote: » On 30 April, HCW, 70+ & Medically vulnerable should be fully inoculated?
ninebeanrows wrote: » How long does immunity take after the one shot J&J? 3 weeks?
The European Medicines Agency could approve the drug for the EU in early March, with a speedy rollout to follow, French Industry Minister Agnès Pannier-Runacher said on Sunday.
brickster69 wrote: » The Czech's to approve Sputnikhttps://www.rt.com/news/516788-czech-sputnik-coronavirus-request/
IRISHSPORTSGUY wrote: » https://www.bbc.com/news/world-us-canada-56226979 Now that is important. It seems the production problems in the US may not necessarily extend to Europe.
Caquas wrote: » As you know it was Embraer’s chart that had its figures wrong, showing the Lithuanian figure for Ireland. And, as I said. that didn’t change my key point - there were no grounds for calling our vaccine rollout “exceptionally good” At least we seem to have gone beyond the premature self-congratulations here and the “how many times must I tell you” or “ignore him” nonsense. I never claimed to have all the answers but I don’t think the British would accept your explanations for their success. And Embraer’s chart did have an important message if s/he wasn’t so complacent. Some of the largest EU countries are not administering the AstraZeneca vaccine efficiently. Why can’t we get their stocks?Europe’s AstraZeneca stockpile mounts as citizens snub jab https://on.ft.com/3ksLM9K And just to be clear, I’d be delighted and impressed if we achieve the 82% target set by the Taoiseach by the end of June. Hell, I’d be impressed if it’s only 81.7% on 1 July. :cool: